Buscador de publicaciones

 
 
 
 
 

Mostrando 331 a 345 de 1626 publicaciones.

  • Tajes M, Eraso-Pichot A, Rubio-Moscardo F, Guivernau B, Ramos-Fernández E, Bosch-Morató M, Guix FX, Clarimón J, Miscione GP, Boada M, Gil-Gómez G, Suzuki T, Molina H, Villà-Freixa J, Vicente R, Muñoz FJ. Methylglyoxal produced by amyloid-β peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer's disease. J. Alzheimers Dis. 2014; 41(1): 273-88

    IF: 3.612, Cuartil: 2

    Ver abstract

  • Tajes M, Eraso-Pichot A, Rubio-Moscardo F, Guivernau B, Bosch-Morató M, Valls-Comamala V, Muñoz FJ. Methylglyoxal reduces mitochondrial potential and activates Bax and caspase-3 in neurons: Implications for Alzheimer's disease. Neurosci. Lett. 2014 Sep; 580: 78-82

    IF: 2.03, Cuartil: 3

    Ver abstract

  • Duarte J, Francisco V, Perez-Vizcaino F. Modulation of nitric oxide by flavonoids. Food Funct 2014 Aug; 5(8): 1653-68

    IF: 2.907, Cuartil: 1

    Ver abstract

  • Escaned J, Echavarria-Pinto M. Moving beyond coronary stenosis: has the time arrived to address important physiological questions not answered by fractional flow reserve alone? Circ Cardiovasc Interv 2014 Jun; 7(3): 282-4

    IF: 6.982, Cuartil: 1, Decil: 1

    Ver abstract

  • Jeremias A, Maehara A, Généreux P, Asrress KN, Berry C, de Bruyne B, Davies JE, Escaned J, Fearon WF, Gould KL, Johnson NP, Kirtane AJ, Koo BK, Marques KM, Nijjer S, Oldroyd KG, Petraco R, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JA, Van't Veer M, van 't Veer M, Mintz GS, Stone GW. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J. Am. Coll. Cardiol. 2014 Apr; 63(13): 1253-61

    IF: 14.086, Cuartil: 1, Decil: 1

    Ver abstract

  • Soria JM, Morange PE, Vila J, Souto JC, Moyano M, Trégouët DA, Mateo J, Saut N, Salas E, Elosua R. Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc 2014 Oct; 3(5): e001060

    IF: 2.882, Cuartil: 2

    Ver abstract

  • Duchateau N, Sitges M, Doltra A, Fernández-Armenta J, Solanes N, Rigol M, Gabrielli L, Silva E, Barcelo A, Berruezo A, Mont L, Brugada J, Bijnens B. Myocardial motion and deformation patterns in an experimental swine model of acute LBBB/CRT and chronic infarct. Int J Cardiovasc Imaging 2014 Jun; 30(5): 875-87

    IF: 2.322, Cuartil: 2

    Ver abstract

  • Buja A, Gini R, Visca M, Damiani G, Federico B, Donato D, Francesconi P, Marini A, Donatini A, Brugaletta S, Bardelle G, Baldo V, Bellentani M. Need and disparities in primary care management of patients with diabetes. BMC Endocr Disord 2014; 14: 56

    IF: 1.673, Cuartil: 3

    Ver abstract

  • Tamargo J, Caballero R, Delpón E. New drugs for the treatment of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors -- hype or hope? Discov Med 2014 Nov; 18(100): 249-54

    IF: 3.503, Cuartil: 2

    Ver abstract

  • Serra G, Baranchuk A, Bayés-De-Luna A, Brugada J, Goldwasser D, Capulzini L, Arazo D, Boraita A, Heras ME, Garcia-Niebla J, Elosua R, Brugada R, Brugada P. New electrocardiographic criteria to differentiate the Type-2 Brugada pattern from electrocardiogram of healthy athletes with r'-wave in leads V1/V2. Europace 2014 Nov; 16(11): 1639-45

    IF: 3.05, Cuartil: 2

    Ver abstract

  • López-Farré AJ, Modrego J, Azcona L, Guerra R, Segura A, Rodríguez P, Zamorano-León JJ, Lahera V, Macaya C. Nitric oxide from mononuclear cells may be involved in platelet responsiveness to aspirin. Eur. J. Clin. Invest. 2014 May; 44(5): 463-9

    IF: 2.834, Cuartil: 1

    Ver abstract

  • Sabaté M, Brugaletta S. Nitric-oxide coated bioactive titanium stents: safer and more effective than second-generation drug-eluting stents? Rev Esp Cardiol (Engl Ed) 2014 Jul; 67(7): 511-3

    IF: 3.792, Cuartil: 2

    Ver abstract

  • Wildhagen KC, García de Frutos P, Reutelingsperger CP, Schrijver R, Aresté C, Ortega-Gómez A, Deckers NM, Hemker HC, Soehnlein O, Nicolaes GA. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood 2014 Feb; 123(7): 1098-101

    IF: 9.775, Cuartil: 1, Decil: 1

    Ver abstract

  • Núñez J, Núñez E, Bodí V, Bayés-Genís A, Sanchis J. Optimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved. Int. J. Cardiol. 2014 Jun; 174(2): 457-8

    IF: 6.175, Cuartil: 1, Decil: 1

    Ver abstract

  • Han JK, Koo BK, Park KW, Ben-Dor I, Waksman R, Pichard A, Nam CW, Doh JH, Murata N, Tanaka N, Lee CH, Gonzalo N, Escaned J, Costa MA, Kubo T, Akasaka T, Hu X, Wang J, Yang HM, Yoon MH, Tahk SJ, Ma S, Park SK, Kim HS. Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study. Cardiology 2014; 127(4): 256-62

    IF: 2.044, Cuartil: 3

    Ver abstract

Una iniciativa de

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar